Effects of COVID-19 on Intravitreal Injection Clinic After Lockdown.

Terry HsiehBradley S GundlachSahar AshrafzadehDavid SarrafIrena Tsui

Published in: Clinical ophthalmology (Auckland, N.Z.) (2022)

Injection volume returned to pre-pandemic levels immediately after lockdown ended. However, patients with high-risk comorbidities did not return to intravitreal injection clinic post-lockdown. These results can inform medical organizations, which groups may need increased safety measures and targeted outreach to address their ophthalmic needs.

Keyphrases

coronavirus disease
sars cov
ultrasound guided
vascular endothelial growth factor
primary care
diabetic retinopathy
age related macular degeneration
respiratory syndrome coronavirus